Über uns

Vectura's product development, formulation and drug delivery expertise is centred around developing inhaled products to address unmet needs in airways diseases.

Vectura has established development collaborations, joint ventures and license agreements with several global pharmaceutical and biotechnology companies.

Vectura is based in the UK, with headquarters in Chippenham, Wiltshire (UK) and operates in Cambridge (UK), Gauting (Germany),  Muttenz  (Switzerland) and Lyon (France).